IM Cannabis (IMCC) EPS (Diluted) Growth (1y) (2020 - 2026)
IM Cannabis (IMCC) EPS (Diluted) Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | -857.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -857.97% |
| Mar 31, 2026 | -776.86% |
| Dec 31, 2025 | 65.79% |
| Sep 30, 2025 | 280.12% |
| Jun 30, 2025 | 80.97% |
| Mar 31, 2025 | 102.61% |
| Dec 31, 2024 | -6.84% |
| Sep 30, 2024 | -123.71% |
| Jun 30, 2024 | -1,187,172,249.92% |
| Mar 31, 2024 | -292.71% |
| Dec 31, 2023 | 51.74% |
| Sep 30, 2023 | 101.61% |
| Jun 30, 2023 | 107.58% |
| Mar 31, 2023 | 81.64% |
| Dec 31, 2022 | 48.92% |
| Sep 30, 2022 | -1,270.39% |
| Jun 30, 2022 | 100.00% |
| Mar 31, 2022 | -150.03% |
| Dec 31, 2021 | -2.65% |
| Sep 30, 2021 | 552.22% |